Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 6:10:1010205.
doi: 10.3389/fped.2022.1010205. eCollection 2022.

Editorial: Perinatal assessment of biomarkers in invasive and non-invasive procedures of biological fluid collection

Iliana Bersani  1 , Diego Gazzolo  2 , Fiammetta Piersigilli  3
Affiliations
Editorial

Editorial: Perinatal assessment of biomarkers in invasive and non-invasive procedures of biological fluid collection

Iliana Bersani et al. Front Pediatr. .
No abstract available

Keywords: biological fluids; biomarker; diagnosis; neonate; theranostics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Perinatal assessment of biomarkers in invasive and non-invasive procedures of biological fluid collection

References

    1. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. (2010) 5:463–6. 10.1097/COH.0b013e32833ed177 - DOI - PMC - PubMed
    1. Califf RM. Biomarker definitions and their applications. Exp Biol Med. (2018) 243:213–21. 10.1177/1535370217750088 - DOI - PMC - PubMed
    1. Gromova M, Vaggelas A, Dallmann G, Seimetz D. Biomarkers: opportunities and challenges for drug development in the current regulatory landscape. Biomark Insights. (2020) 15:1177271920974652. 10.1177/1177271920974652 - DOI - PMC - PubMed
    1. FDA . Critical Path Opportunities Report (2006). Available online at: http://www.slcmsr.net/download/yer/Critical_Path_Initiative_Report_FDA_2... (accessed March 11, 2020).
    1. FDA-NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring, MD; Bethesda, MD: Food Drug Administration; National Institutes of Healt; (2016). Available online at: www.ncbi.nlm.nih.gov/books/NBK326791/ (accessed September 22, 2017). - PubMed

Publication types

LinkOut - more resources